Long-Term Effects of a 12-Week Exercise Training Program on Clinical Outcomes in Idiopathic Pulmonary Fibrosis
Purpose Idiopathic pulmonary fibrosis (IPF) is a chronic, devastating, lung disease, with few therapeutic options. Data are limited with respect to the long-term effect of exercise training (ET) in IPF. This study sought to evaluate the long-term effects of a 12-week ET program on clinical outcomes...
Gespeichert in:
Veröffentlicht in: | Lung 2015-06, Vol.193 (3), p.345-354 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 354 |
---|---|
container_issue | 3 |
container_start_page | 345 |
container_title | Lung |
container_volume | 193 |
creator | Vainshelboim, Baruch Oliveira, Jose Fox, Benjamin Daniel Soreck, Yafit Fruchter, Oren Kramer, Mordechai Reuven |
description | Purpose
Idiopathic pulmonary fibrosis (IPF) is a chronic, devastating, lung disease, with few therapeutic options. Data are limited with respect to the long-term effect of exercise training (ET) in IPF. This study sought to evaluate the long-term effects of a 12-week ET program on clinical outcomes in IPF patients.
Methods
Thirty-four IPF patients were randomly allocated to ET or control groups. ET group participated in a 12-week supervised exercise program, while the control group continued with regular medical treatment alone. Exercise capacity, 30 s-chair-stand test for leg strength, dyspnea, and Saint George’s Respiratory Questionnaire (SGRQ) for quality of life (QOL) were assessed at baseline and re-evaluated at 11 months from baseline. In addition, at 30-month time point from baseline, the impact of the 12-week intervention was analyzed with respect to survival and cardio-respiratory-related hospitalizations.
Results
Thirty-two patients completed the 12-week intervention and 28 patients (14 in each group) were re-evaluated. At 11-month follow-up, no significant differences between the groups and time effect were demonstrated for most outcomes. ET group showed preserved values at the baseline level while the control group showed a trend of deterioration. Only the 30 s-chair-stand test (mean difference 3 stands,
p
= 0.01) and SGRQ (mean difference −6 units,
p
= 0.037) were significantly different between the groups. At 30 months, the survival analysis showed three deaths, eight hospitalizations occurred in the control group versus one death, one lung transplantation and seven hospitalizations in the ET group, with no significant differences between groups.
Conclusions
At 11-month follow-up, the 12-week ET program showed clinical outcomes were preserved at baseline levels with some maintenance of improvements in leg strength and QOL in the ET group. The control group showed a trend of deterioration in the outcomes. At 30 months, the 12-week ET program did not show benefits in prognosis although the study was underpowered to detect such differences. We suggest including ET as a long-term continued treatment and as a core component of pulmonary rehabilitation programs for IPF patients. |
doi_str_mv | 10.1007/s00408-015-9703-0 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1681265029</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A435334969</galeid><sourcerecordid>A435334969</sourcerecordid><originalsourceid>FETCH-LOGICAL-c574t-7bac67a263687c235dcca932809cafa154307e35deb0767ad13b90c56653a3eb3</originalsourceid><addsrcrecordid>eNp1klFrFDEUhQdR7Fr9Ab5IQBBfUm-SyWTnsSxbLSy0Dys-hkzmzmzqTLImM1D_vVm2aisreQjcfOdwOTlF8ZbBBQNQnxJACUsKTNJagaDwrFiwUnDKlITnxQJEySjPzFnxKqU7AKYqJl8WZ1wqwZSoFoXfBN_TLcaRrLsO7ZRI6IghjNNviN_J-h6jdQnJNhrnne_JbQx9NCMJnqyGPLJmIDfzZMOIiThPrlsX9mbaOUtu52EM3sSf5Mo1MSSXXhcvOjMkfPNwnxdfr9bb1Re6ufl8vbrcUCtVOVHVGFspwytRLZXlQrbWmlrwJdTWdIbJUoDCPMYGVAZbJpoarKwqKYzARpwXH4---xh-zJgmPbpkcRiMxzAnzaol45UEXmf0_T_oXZijz9sdKKhzTpz_pXozoHa-C1M09mCqL0shhSjr6uBFT1A9eoxmCB47l8dP-IsTfD4tjs6eFHx4JNihGaZdCsM8ueDTU5AdQZtzTxE7vY9uzF-hGehDefSxPDqXRx_KoyFr3j0kMTcjtn8Uv9uSAX4EUn7yPcZHUf3X9RcsWMrD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1680917322</pqid></control><display><type>article</type><title>Long-Term Effects of a 12-Week Exercise Training Program on Clinical Outcomes in Idiopathic Pulmonary Fibrosis</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Vainshelboim, Baruch ; Oliveira, Jose ; Fox, Benjamin Daniel ; Soreck, Yafit ; Fruchter, Oren ; Kramer, Mordechai Reuven</creator><creatorcontrib>Vainshelboim, Baruch ; Oliveira, Jose ; Fox, Benjamin Daniel ; Soreck, Yafit ; Fruchter, Oren ; Kramer, Mordechai Reuven</creatorcontrib><description>Purpose
Idiopathic pulmonary fibrosis (IPF) is a chronic, devastating, lung disease, with few therapeutic options. Data are limited with respect to the long-term effect of exercise training (ET) in IPF. This study sought to evaluate the long-term effects of a 12-week ET program on clinical outcomes in IPF patients.
Methods
Thirty-four IPF patients were randomly allocated to ET or control groups. ET group participated in a 12-week supervised exercise program, while the control group continued with regular medical treatment alone. Exercise capacity, 30 s-chair-stand test for leg strength, dyspnea, and Saint George’s Respiratory Questionnaire (SGRQ) for quality of life (QOL) were assessed at baseline and re-evaluated at 11 months from baseline. In addition, at 30-month time point from baseline, the impact of the 12-week intervention was analyzed with respect to survival and cardio-respiratory-related hospitalizations.
Results
Thirty-two patients completed the 12-week intervention and 28 patients (14 in each group) were re-evaluated. At 11-month follow-up, no significant differences between the groups and time effect were demonstrated for most outcomes. ET group showed preserved values at the baseline level while the control group showed a trend of deterioration. Only the 30 s-chair-stand test (mean difference 3 stands,
p
= 0.01) and SGRQ (mean difference −6 units,
p
= 0.037) were significantly different between the groups. At 30 months, the survival analysis showed three deaths, eight hospitalizations occurred in the control group versus one death, one lung transplantation and seven hospitalizations in the ET group, with no significant differences between groups.
Conclusions
At 11-month follow-up, the 12-week ET program showed clinical outcomes were preserved at baseline levels with some maintenance of improvements in leg strength and QOL in the ET group. The control group showed a trend of deterioration in the outcomes. At 30 months, the 12-week ET program did not show benefits in prognosis although the study was underpowered to detect such differences. We suggest including ET as a long-term continued treatment and as a core component of pulmonary rehabilitation programs for IPF patients.</description><identifier>ISSN: 0341-2040</identifier><identifier>EISSN: 1432-1750</identifier><identifier>DOI: 10.1007/s00408-015-9703-0</identifier><identifier>PMID: 25731736</identifier><identifier>CODEN: LUNGD9</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Aged ; Care and treatment ; Clinical outcomes ; Exercise ; Exercise Test ; Exercise Therapy ; Exercise Tolerance ; Female ; Hospitalization ; Humans ; Idiopathic Pulmonary Fibrosis - diagnosis ; Idiopathic Pulmonary Fibrosis - mortality ; Idiopathic Pulmonary Fibrosis - physiopathology ; Idiopathic Pulmonary Fibrosis - therapy ; Israel ; Legs ; Lung - pathology ; Lung - physiopathology ; Lung Transplantation ; Male ; Medicine ; Medicine & Public Health ; Methods ; Middle Aged ; Muscle Strength ; Patient outcomes ; Pneumology/Respiratory System ; Pulmonary fibrosis ; Quality of Life ; Recovery of Function ; Surveys and Questionnaires ; Time Factors ; Treatment Outcome</subject><ispartof>Lung, 2015-06, Vol.193 (3), p.345-354</ispartof><rights>Springer Science+Business Media New York 2015</rights><rights>COPYRIGHT 2015 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c574t-7bac67a263687c235dcca932809cafa154307e35deb0767ad13b90c56653a3eb3</citedby><cites>FETCH-LOGICAL-c574t-7bac67a263687c235dcca932809cafa154307e35deb0767ad13b90c56653a3eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00408-015-9703-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00408-015-9703-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25731736$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vainshelboim, Baruch</creatorcontrib><creatorcontrib>Oliveira, Jose</creatorcontrib><creatorcontrib>Fox, Benjamin Daniel</creatorcontrib><creatorcontrib>Soreck, Yafit</creatorcontrib><creatorcontrib>Fruchter, Oren</creatorcontrib><creatorcontrib>Kramer, Mordechai Reuven</creatorcontrib><title>Long-Term Effects of a 12-Week Exercise Training Program on Clinical Outcomes in Idiopathic Pulmonary Fibrosis</title><title>Lung</title><addtitle>Lung</addtitle><addtitle>Lung</addtitle><description>Purpose
Idiopathic pulmonary fibrosis (IPF) is a chronic, devastating, lung disease, with few therapeutic options. Data are limited with respect to the long-term effect of exercise training (ET) in IPF. This study sought to evaluate the long-term effects of a 12-week ET program on clinical outcomes in IPF patients.
Methods
Thirty-four IPF patients were randomly allocated to ET or control groups. ET group participated in a 12-week supervised exercise program, while the control group continued with regular medical treatment alone. Exercise capacity, 30 s-chair-stand test for leg strength, dyspnea, and Saint George’s Respiratory Questionnaire (SGRQ) for quality of life (QOL) were assessed at baseline and re-evaluated at 11 months from baseline. In addition, at 30-month time point from baseline, the impact of the 12-week intervention was analyzed with respect to survival and cardio-respiratory-related hospitalizations.
Results
Thirty-two patients completed the 12-week intervention and 28 patients (14 in each group) were re-evaluated. At 11-month follow-up, no significant differences between the groups and time effect were demonstrated for most outcomes. ET group showed preserved values at the baseline level while the control group showed a trend of deterioration. Only the 30 s-chair-stand test (mean difference 3 stands,
p
= 0.01) and SGRQ (mean difference −6 units,
p
= 0.037) were significantly different between the groups. At 30 months, the survival analysis showed three deaths, eight hospitalizations occurred in the control group versus one death, one lung transplantation and seven hospitalizations in the ET group, with no significant differences between groups.
Conclusions
At 11-month follow-up, the 12-week ET program showed clinical outcomes were preserved at baseline levels with some maintenance of improvements in leg strength and QOL in the ET group. The control group showed a trend of deterioration in the outcomes. At 30 months, the 12-week ET program did not show benefits in prognosis although the study was underpowered to detect such differences. We suggest including ET as a long-term continued treatment and as a core component of pulmonary rehabilitation programs for IPF patients.</description><subject>Aged</subject><subject>Care and treatment</subject><subject>Clinical outcomes</subject><subject>Exercise</subject><subject>Exercise Test</subject><subject>Exercise Therapy</subject><subject>Exercise Tolerance</subject><subject>Female</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>Idiopathic Pulmonary Fibrosis - diagnosis</subject><subject>Idiopathic Pulmonary Fibrosis - mortality</subject><subject>Idiopathic Pulmonary Fibrosis - physiopathology</subject><subject>Idiopathic Pulmonary Fibrosis - therapy</subject><subject>Israel</subject><subject>Legs</subject><subject>Lung - pathology</subject><subject>Lung - physiopathology</subject><subject>Lung Transplantation</subject><subject>Male</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methods</subject><subject>Middle Aged</subject><subject>Muscle Strength</subject><subject>Patient outcomes</subject><subject>Pneumology/Respiratory System</subject><subject>Pulmonary fibrosis</subject><subject>Quality of Life</subject><subject>Recovery of Function</subject><subject>Surveys and Questionnaires</subject><subject>Time Factors</subject><subject>Treatment Outcome</subject><issn>0341-2040</issn><issn>1432-1750</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp1klFrFDEUhQdR7Fr9Ab5IQBBfUm-SyWTnsSxbLSy0Dys-hkzmzmzqTLImM1D_vVm2aisreQjcfOdwOTlF8ZbBBQNQnxJACUsKTNJagaDwrFiwUnDKlITnxQJEySjPzFnxKqU7AKYqJl8WZ1wqwZSoFoXfBN_TLcaRrLsO7ZRI6IghjNNviN_J-h6jdQnJNhrnne_JbQx9NCMJnqyGPLJmIDfzZMOIiThPrlsX9mbaOUtu52EM3sSf5Mo1MSSXXhcvOjMkfPNwnxdfr9bb1Re6ufl8vbrcUCtVOVHVGFspwytRLZXlQrbWmlrwJdTWdIbJUoDCPMYGVAZbJpoarKwqKYzARpwXH4---xh-zJgmPbpkcRiMxzAnzaol45UEXmf0_T_oXZijz9sdKKhzTpz_pXozoHa-C1M09mCqL0shhSjr6uBFT1A9eoxmCB47l8dP-IsTfD4tjs6eFHx4JNihGaZdCsM8ueDTU5AdQZtzTxE7vY9uzF-hGehDefSxPDqXRx_KoyFr3j0kMTcjtn8Uv9uSAX4EUn7yPcZHUf3X9RcsWMrD</recordid><startdate>20150601</startdate><enddate>20150601</enddate><creator>Vainshelboim, Baruch</creator><creator>Oliveira, Jose</creator><creator>Fox, Benjamin Daniel</creator><creator>Soreck, Yafit</creator><creator>Fruchter, Oren</creator><creator>Kramer, Mordechai Reuven</creator><general>Springer US</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>K9-</scope><scope>K9.</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7N</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20150601</creationdate><title>Long-Term Effects of a 12-Week Exercise Training Program on Clinical Outcomes in Idiopathic Pulmonary Fibrosis</title><author>Vainshelboim, Baruch ; Oliveira, Jose ; Fox, Benjamin Daniel ; Soreck, Yafit ; Fruchter, Oren ; Kramer, Mordechai Reuven</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c574t-7bac67a263687c235dcca932809cafa154307e35deb0767ad13b90c56653a3eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Care and treatment</topic><topic>Clinical outcomes</topic><topic>Exercise</topic><topic>Exercise Test</topic><topic>Exercise Therapy</topic><topic>Exercise Tolerance</topic><topic>Female</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>Idiopathic Pulmonary Fibrosis - diagnosis</topic><topic>Idiopathic Pulmonary Fibrosis - mortality</topic><topic>Idiopathic Pulmonary Fibrosis - physiopathology</topic><topic>Idiopathic Pulmonary Fibrosis - therapy</topic><topic>Israel</topic><topic>Legs</topic><topic>Lung - pathology</topic><topic>Lung - physiopathology</topic><topic>Lung Transplantation</topic><topic>Male</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methods</topic><topic>Middle Aged</topic><topic>Muscle Strength</topic><topic>Patient outcomes</topic><topic>Pneumology/Respiratory System</topic><topic>Pulmonary fibrosis</topic><topic>Quality of Life</topic><topic>Recovery of Function</topic><topic>Surveys and Questionnaires</topic><topic>Time Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vainshelboim, Baruch</creatorcontrib><creatorcontrib>Oliveira, Jose</creatorcontrib><creatorcontrib>Fox, Benjamin Daniel</creatorcontrib><creatorcontrib>Soreck, Yafit</creatorcontrib><creatorcontrib>Fruchter, Oren</creatorcontrib><creatorcontrib>Kramer, Mordechai Reuven</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Lung</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vainshelboim, Baruch</au><au>Oliveira, Jose</au><au>Fox, Benjamin Daniel</au><au>Soreck, Yafit</au><au>Fruchter, Oren</au><au>Kramer, Mordechai Reuven</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Long-Term Effects of a 12-Week Exercise Training Program on Clinical Outcomes in Idiopathic Pulmonary Fibrosis</atitle><jtitle>Lung</jtitle><stitle>Lung</stitle><addtitle>Lung</addtitle><date>2015-06-01</date><risdate>2015</risdate><volume>193</volume><issue>3</issue><spage>345</spage><epage>354</epage><pages>345-354</pages><issn>0341-2040</issn><eissn>1432-1750</eissn><coden>LUNGD9</coden><abstract>Purpose
Idiopathic pulmonary fibrosis (IPF) is a chronic, devastating, lung disease, with few therapeutic options. Data are limited with respect to the long-term effect of exercise training (ET) in IPF. This study sought to evaluate the long-term effects of a 12-week ET program on clinical outcomes in IPF patients.
Methods
Thirty-four IPF patients were randomly allocated to ET or control groups. ET group participated in a 12-week supervised exercise program, while the control group continued with regular medical treatment alone. Exercise capacity, 30 s-chair-stand test for leg strength, dyspnea, and Saint George’s Respiratory Questionnaire (SGRQ) for quality of life (QOL) were assessed at baseline and re-evaluated at 11 months from baseline. In addition, at 30-month time point from baseline, the impact of the 12-week intervention was analyzed with respect to survival and cardio-respiratory-related hospitalizations.
Results
Thirty-two patients completed the 12-week intervention and 28 patients (14 in each group) were re-evaluated. At 11-month follow-up, no significant differences between the groups and time effect were demonstrated for most outcomes. ET group showed preserved values at the baseline level while the control group showed a trend of deterioration. Only the 30 s-chair-stand test (mean difference 3 stands,
p
= 0.01) and SGRQ (mean difference −6 units,
p
= 0.037) were significantly different between the groups. At 30 months, the survival analysis showed three deaths, eight hospitalizations occurred in the control group versus one death, one lung transplantation and seven hospitalizations in the ET group, with no significant differences between groups.
Conclusions
At 11-month follow-up, the 12-week ET program showed clinical outcomes were preserved at baseline levels with some maintenance of improvements in leg strength and QOL in the ET group. The control group showed a trend of deterioration in the outcomes. At 30 months, the 12-week ET program did not show benefits in prognosis although the study was underpowered to detect such differences. We suggest including ET as a long-term continued treatment and as a core component of pulmonary rehabilitation programs for IPF patients.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>25731736</pmid><doi>10.1007/s00408-015-9703-0</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0341-2040 |
ispartof | Lung, 2015-06, Vol.193 (3), p.345-354 |
issn | 0341-2040 1432-1750 |
language | eng |
recordid | cdi_proquest_miscellaneous_1681265029 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Aged Care and treatment Clinical outcomes Exercise Exercise Test Exercise Therapy Exercise Tolerance Female Hospitalization Humans Idiopathic Pulmonary Fibrosis - diagnosis Idiopathic Pulmonary Fibrosis - mortality Idiopathic Pulmonary Fibrosis - physiopathology Idiopathic Pulmonary Fibrosis - therapy Israel Legs Lung - pathology Lung - physiopathology Lung Transplantation Male Medicine Medicine & Public Health Methods Middle Aged Muscle Strength Patient outcomes Pneumology/Respiratory System Pulmonary fibrosis Quality of Life Recovery of Function Surveys and Questionnaires Time Factors Treatment Outcome |
title | Long-Term Effects of a 12-Week Exercise Training Program on Clinical Outcomes in Idiopathic Pulmonary Fibrosis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T17%3A01%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Long-Term%20Effects%20of%20a%2012-Week%20Exercise%20Training%20Program%20on%20Clinical%20Outcomes%20in%20Idiopathic%20Pulmonary%20Fibrosis&rft.jtitle=Lung&rft.au=Vainshelboim,%20Baruch&rft.date=2015-06-01&rft.volume=193&rft.issue=3&rft.spage=345&rft.epage=354&rft.pages=345-354&rft.issn=0341-2040&rft.eissn=1432-1750&rft.coden=LUNGD9&rft_id=info:doi/10.1007/s00408-015-9703-0&rft_dat=%3Cgale_proqu%3EA435334969%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1680917322&rft_id=info:pmid/25731736&rft_galeid=A435334969&rfr_iscdi=true |